Stocks Health care STIM
NASDAQ · Health careNeuronetics, Inc. (STIM)
Neuronetics, Inc. brought in $155.1M of revenue over the twelve months to June 30, 2026, up 39.6% from a year earlier. It posted a net loss of $30.4M. In fiscal 2025 capital spending exceeded operating cash flow by $21.2M. At June 30, 2026 it held $19.2M in cash against $61.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.
What Neuronetics, Inc. does
Neuronetics, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker STIM.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $149.2M | -$39M | -$0.59 | -$21.2M |
| 2024 | $74.9M | -$43.7M | -$1.38 | -$32.5M |
| 2023 | $71.3M | -$30.2M | -$1.05 | -$34.4M |
| 2022 | $65.2M | -$37.2M | -$1.38 | -$34M |
| 2021 | $55.3M | -$31.2M | -$1.22 | -$30.3M |
| 2020 | $49.2M | -$27.5M | -$1.46 | -$29.1M |
Latest SEC filings
What Neuronetics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 24, 2026Activist stake changed SCHEDULE 13D/A
- August 17, 2026
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 11, 2026
- August 11, 2026Quarterly report 10-Q · period to June 30, 2026
- August 11, 2026
- August 4, 2026Activist stake changed SCHEDULE 13D/A
- July 20, 2026
- June 23, 2026
- May 29, 2026
Questions about STIM
What does Neuronetics, Inc. do?
Neuronetics, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker STIM.
Is Neuronetics, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $30.4M on revenue of $155.1M.
How much revenue does Neuronetics, Inc. make?
Over the twelve months to June 30, 2026 Neuronetics, Inc. reported revenue of $155.1M. That is 39.6% more than a year earlier.
When did Neuronetics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the activist stake changed from August 24, 2026.
Similar companies
Follow STIM
Get an email when Neuronetics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow STIM: get an email when it filesWhere the numbers come from
Financial figures are the values Neuronetics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.